<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Which Type of Plaque is Better? - EEC007</title>
  <description>There exist 3 common types of eye-plaques used to destroy choroidal melanomas. They include: beta-emitters (ruthenium-106, Strontium-90) and seeded plaques iodine-125, palladium-103. The beta-emitters are popular in low socio-economic environments because they can be re-used for many patients. Iodine-125 gained its popularity as a treatment arm for the North American Collaborative Ocular Melanoma Study. The use of palladium-103 seeds in gold eye plaques was invented by Dr. Finger in 1991. Since that time, 6 North American Centers have adopted its use. Both the American Brachytherapy Society and the American Association of Physicists in Medicine have demonstrated advantages related to palladium-103. Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170 </description>
  <author_name>Essential Eye Cancer Podcast</author_name>
  <author_url>http://eyecancer.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/13096313/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/64573166</thumbnail_url>
</oembed>
